AMP

Amphastar Pharms Stock

StockStock
ISIN: US03209R1032
Ticker: AMPH
US03209R1032
AMPH

Price

Historical dividends and forecast

All dividend data

 


$0.30

CHART BY

Frequently asked questions

What is Amphastar Pharms's market capitalization?

The market capitalization of Amphastar Pharms is $2.35B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Amphastar Pharms's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Amphastar Pharms is 16.16. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Amphastar Pharms?

Amphastar Pharms's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $3.005. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Amphastar Pharms's stock?

Currently, 6 analysts cover Amphastar Pharms's stock, with a consensus target price of $63.25. Analyst ratings provide insights into the stock's expected performance.

What is Amphastar Pharms's revenue over the trailing twelve months?

Over the trailing twelve months, Amphastar Pharms reported a revenue of $723.55M.

What is the EBITDA for Amphastar Pharms?

Amphastar Pharms's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $266.61M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Amphastar Pharms?

Amphastar Pharms has a free cash flow of $170.15M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Amphastar Pharms's stock?

The 5-year beta for Amphastar Pharms is 0.81. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Amphastar Pharms have, and what sector and industry does it belong to?

Amphastar Pharms employs approximately 1,761 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Amphastar Pharms's shares?

The free float of Amphastar Pharms is 37.50M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 
$2.35B

5Y beta

 
0.81

EPS (TTM)

 
$3.005

Free Float

 
37.50M

P/E ratio (TTM)

 
16.16

Revenue (TTM)

 
$723.55M

EBITDA (TTM)

 
$266.61M

Free Cashflow (TTM)

 
$170.15M

Pricing

52W span
$36.56$65.92

Analyst Ratings

The price target is $63.25 and the stock is covered by 6 analysts.

Buy

4

Hold

2

Sell

0

Information

Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically challenging generic and injectable, inhalation, and intranasal products. Additionally, it sells insulin API products. Most of its finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers. Its segments include finished pharmaceutical products and API products. The finished pharmaceutical products segment manufactures, markets and distributes Primatene MIST, epinephrine, glucagon, phytonadione, lidocaine, enoxaparin, naloxone, as well as various other critical and non-critical care drugs. The API segment manufactures and distributes RHI API and porcine insulin API for external customers and internal product development. Its pipeline has over 20 product candidates, including generic ANDAs, biosimilar, and others.

1,761

Biotechnology & Drugs

Health Care

Identifier

ISIN

US03209R1032

Primary Ticker

AMPH

Knockouts

Join the conversation